Good Recovery at One Year for Most COVID-19 Hospital Survivors
However, survivors had more problems with mobility, pain or discomfort, anxiety or depression at one year than controls
Pain Management Skills Class Aids Those With Chronic Low Back Pain
Findings show noninferior outcomes at three months versus cognitive behavioral therapy
Neurocognitive Effects of Ketamine for Depression Examined
Findings based on a systematic literature review of studies reporting the use of ketamine, esketamine for treatment-resistant depression
COVID-19 Vaccine Hesitancy Up for Racial, Ethnic Minority HCWs
Vaccine hesitancy highest among Black and Hispanic or Latino health care workers; concerns include side effects, newness of vaccine
Cognitive Remediation Benefits Patients With Schizophrenia
Benefits include cognitive and functional outcomes even for severely affected patients
Adults With Disabilities Have Worse Mental Health During COVID-19
Adults with disabilities more often report that the pandemic makes it harder for them to access care, medication
Physician’s Briefing Weekly Coronavirus Roundup
Dementia Risk Score Linked to MRI Markers of Brain Atrophy
Higher scores on Lifestyle for Brain Health index linked to higher volumes of white matter hyperintensities, lower scores for cognitive function
Most Children Experience Fluctuations in ADHD Symptoms
While nearly one in three will experience points of remission of ADHD symptoms, most experience recurrence over time and few outgrow it
2019 to 2020 Saw Increase in Benzodiazepine Overdose ED Visits
Benzodiazepine deaths increased from April-June 2019 to April-June 2020, with larger increase for illicit benzodiazepine deaths
